Abstract : The pharmaceutical sector is undergoing unprecedented transformations, driven by unique factors. On the demand side, there is a noticeable shift with an aging population, heightened prevalence of "Western" diseases, and a substantial increase in global access to pharmaceuticals. Simultaneously, the supply side is witnessing heightened competition from emerging market players, coupled with a change in the approaches to drug development, manufacturing, and delivery.
Keywords :
Cite : Setia, A., & Khanna, A. (2023). Market Opportunity Analysis For Biosimilars From Perspective Of Regulatory Environment Offered In Eu5, U.S., Japan And Pharmerging Markets (1st ed., pp. 60-64). Noble Science Press. https://doi.org/10.52458/9788196897475.2023.eb.ch-15
